Back to search
FDAFDA · Food and drugs·Recall number D-0284-2023

D5 NS 2300ML, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,

Published February 22, 2023 · Recall initiated: December 27, 2022

Summary

FDA records drug Class II recall D-0284-2023, published February 22, 2023 and initiated December 27, 2022. Recalling firm: Sentara Infusion Services; Status: Terminated; Reported quantity: 2; Lot: Beyond Use Date: December 26, 2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of sterility assurance

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sentara Infusion Services
Distributor
Dispensed to Patients Nationwide.
Lot
Beyond Use Date: December 26, 2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was D5 NS 2300ML, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320, recalled?

Yes. FDA published recall D-0284-2023 on February 22, 2023. Reported hazard: Lack of sterility assurance

What should I do if I have this product?

Voluntary: Firm initiated · Telephone